Results 281 to 290 of about 19,887 (300)

Drug Interactions With Direct-Acting Antivirals for Hepatitis C

Annals of Pharmacotherapy, 2015
Nilufar Partovi, Eric M Yoshida, Siegfried R Erb   +2 more
exaly  

Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals

Journal of Clinical and Experimental Hepatology, 2020
Kellie Young, Benny Liu, Taft Bhuket
exaly  

Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!

Dermatologic Therapy, 2019
Ayman Abdelmaksoud, Michelangelo Vestita
openaire   +2 more sources

Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam

Value in Health, 2020
Ammarin Thakkinstian, Montarat Thavorncharoensap, Abhasnee Sobhonslidsuk   +2 more
exaly  

Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program

Journal of Substance Abuse Treatment, 2017
Julia M Shi, Jeanette M Tetrault
exaly  

Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease

Therapeutic Advances in Gastroenterology, 2016
Robert G Gish
exaly  

The Era of Direct-Acting Antivirals Has Begun: The Beginning of the End for HCV?

Seminars in Liver Disease, 2011
Douglas T Dieterich
exaly  

Current therapy for chronic hepatitis C: The role of direct-acting antivirals

Antiviral Research, 2017
Guangdi Li, Erik De Clercq
exaly  

Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma

Leukemia and Lymphoma, 2020
Michele Merli, Carlo Visco, Caroline Besson   +2 more
exaly  

Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

Expert Review of Gastroenterology and Hepatology, 2018
Jaume Puig-Junoy, Natalia Pascual-Argente   +1 more
exaly